Our board members come from diverse backgrounds with expertise in medicine, stem-cell research, finance, management, business development, and high-growth startups.
Christof Westenfelder, MD
Founder, CEO, and Chairman of the Board of Manager
Dr. Westenfelder is a Professor of Medicine and Physiology at the University of Utah and Chief of the Nephrology Section of the VA Medical Center. Dr. Westenfelder has extensive experience in clinical and basic research in the field of adult stem cell biology, stem cell translational research with an emphasis in the fields of transplantation medicine and renal and critical care. In addition, Dr. Westenfelder is an internationally recognized expert on the biology and clinical uses of erythropoietin and treatment of acute kidney and multi-organ failure. Dr. Westenfelder has successfully founded a number of companies including Nephrogen, SymbioCellTech, LLC and Nephrocelltech, and he holds numerous patents pertinent to SCT’s technology. He has obtained an IND from the FDA for the conduct of a successful Phase I Trial in which the safety and kidney protective activity of allogeneic, bone marrow-derived Multipotent Stromal aka Mesenchymal Stem Cells was demonstrated.
Axel Zander, MD
Founder and Vice President
Dr. Zander is emeritus Professor of Medicine and Manager of the Bone Marrow Transplantation Center at the University of Hamburg in Germany. Dr. Zander is an internationally recognized expert in bone marrow transplantation and stem cell research, with particular expertise in novel clinical uses of adult stem cells in regenerative medicine. Dr. Zander has founded and co-founded a number of companies including Nephrogen, SymbioCellTech, LLC and Stem Cell Rescue, and he holds numerous patents related to steam-cell therapy.
Anna Gooch, PhD
Chief Scientific Officer
Dr. Gooch graduated from the University of Utah with a PhD in Cellular, Viral and Molecular Biology. Her previous experience includes her position as Clinical Operations Manager at Allocure, Inc. She assisted in overseeing and managing a Phase 1 Clinical trial for a novel treatment of AKI, and oversaw and consulted on preclinical research. Dr. Gooch’s current duties include overseeing and conducting physical preclinical research in preparation of a Phase I/II clinical trial.
George Russell Reiss, MD
Scientific, Clinical, and Industry Advisor
Dr. Reiss is a highly experienced Cardiothoracic Surgeon and investigator who currently serves as the Director of the Heart Valve Clinic and Transcatheter Valve Therapies, Dean Clinic & St. Mary’s Cardiac Center, Madison, WI. He has extensive experience and training in the field of Regenerative Medicine, Cell Therapy and therapeutic use of adult Stem Cells in cardiac patients. He worked successfully with the FDA and obtained an IND for the treatment of patients with ischemic heart disease, using bone marrow-derived precursor cells. He has previously collaborated with the SCT investigators and contributes excellent skills as a scientific and regulatory advisor to the ongoing work of this company.
Robert Maddock, MBA
Financial and Investment Advisor
Mr. Maddock is a Senior Vice President and a member of the Investment Committee at Inverness Counsel LLC, in New York City. In addition to managing portfolios for high net worth clients, pensions and other institutions, he conducts fundamental research on energy stocks. Prior to joining Inverness in 1993, Mr. Maddock worked at White Oak Capital Management and was an Investment Officer at the Bank of New York. He earned a BA from the University of Utah in 1985 and an MBA from New York University in 1992. Mr. Maddock serves as a Trustee and has served as a Vice President for the Putnam County Land Trust.
Susan McKeever, CPA, EA, MPAcc
Chief Financial Officer
Ms. McKeever has a Bachelor of Science in Business from the University of Southern California and a Masters in Accounting from Weber State University. She is a Certified Public Accountant and an Enrolled Agent. Her experience includes positions as an Auditor and Senior Auditor for Price Waterhouse & Co., Manager of Accounting for United Technologies-Lexar, Division Controller for Southwestern Portland Cement Co., Chief Financial Officer for Prime Thyme Herbs, and Director of Accounting for SOS Staffing Services. Ms. McKeever has also held positions in private industries as Treasurer and Chief Financial Officer. She oversees financial, managerial and administrative functions and liaises with investors.
Business Development Advisor
Mr. Gardner has a diverse background as an aerospace executive, startup tech lead, and angel investor. He was formally trained as an aeronautical engineer with a specialty in optimal control and artificial intelligence algorithms. He has been the chief architect for special programs at Northrop Grumman where he provided technical leadership of projects exceeding $1B. He also spent several years in the startup world as the chief engineer of AME Unmanned Air Systems where he helped position and grow the company to an eventual acquisition by Lockheed Martin. Mr. Gardner has been called-upon as a national expert to brief the White House, Congress, and Joint Chiefs on strategy and tactics for special operations. He has held leadership roles as a technologist, project manager, and business strategist.
Business Development Advisor
Mr. Holmes is currently a Principal of H2M Capital LLC. He also founded Harbor Capital Partners LLC in 2002 and has been responsible for transaction architecture of nearly 1 Billion in capital placement. In 1999 Mr. Holmes founded Lake Creek Financial where he oversaw all bridge lending and created unique finance packages and products to meet the needs of commercial and private customers. From 1993 to 1999, Mr. Holmes served as Owner and VP at TrueNorth, Inc. where his leadership and contribution helped them gain world-wide notoriety resulting in a merger with Franklin Covey, Inc.